How Technology Can Support Long-Term Transformational Experiences
A free webinar co-hosted with Homecoming on innovative tools to support practitioners before, between, and after sessions
Whether you’re a newly trained or seasoned psychedelic therapist, you know that truly transformational experiences and lasting outcomes requires ongoing client collaboration, guidance, and support. However, many providers simply don’t have the bandwidth to manage everything it takes to achieve this, on top of daily operations.
In this webinar, we’ll discuss the different platforms you can use to support your business and facilitate harmonious patient care experiences. Streamline operations; help clients better prepare and integrate their experience; offer ongoing support in between and after sessions; increase collaboration and engagement; and gain insight into client journeys. Join us for this free webinar to learn more.
Instructor
Lead Trainer
Ingmar Gorman, PhD
Dr. Ingmar Gorman is a psychologist who specializes in helping people who use psychedelics and other psychoactive compounds. He received his clinical training at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University in 2017. Dr. Gorman was formerly the Director of the Psychedelic Education and Continuing Care Program at the Center for Optimal Living and is now the co-founder of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. Along with Dr. Paleos, he is currently site co-principal investigator and therapist on a Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder.
Email
Guest Speakers
Yuriy Blokhin - Homecoming CEO & Founder
Yuriy Blokhin is a proud Ukrainian living in Canada and is the CEO and Founder of Homecoming. Yuriy is also a founding board member of Heroic Hearts Project and Heal Ukraine Trauma. He is passionate about increasing safe access to psychedelic-assisted therapy to help all people, especially veterans around the world. He studied mathematical physics at the University of Waterloo, but dropped out to start working at Kik as its first employee. It eventually became one of the most popular mobile apps globally (300m registered users). He is now studying part-time towards a liberal arts degree in religion and philosophy at Harvard Extension School.
Julia Mirer, MD - Director of Strategy Nushama
Julia Mirer M.D. is a consultant in the emerging field of psychedelic medicine, serving as a bridge between eastern and western practices, committed to merging them to help create a new paradigm for integrative health and wellness.
She was on the road to a career in Pediatrics, but seeing the pitfalls of the current healthcare system, decided to shift gears to explore transformative medicine where she has found her calling in advocacy and education around the responsible use of these medicines. Dr. Mirer believes that a successful future for this field depends on the interplay between policy, research, and clinics and has therefore positioned herself to play a role in each.
Nationally, Dr. Mirer is an advisor for the Psychedelic Medicine Coalition which is lobbying for psychedelic research funding. In Florida, she works in psychedelic clinical research at Segal Trials as a facilitator, most recently for USONA’s phase 2 trial using Psilocybin for Major Depression. She serves as the Director of Strategy at Nushama, where she hopes to combine all her experience to create the vision of a new kind of healthcare system and facilitate Nushama’s goal of humanizing medicine.
Webinar in collaboration with
